Recombinant EGFR/MMP-2 bi-targeted fusion protein markedly binding to non-small-cell lung carcinoma and exerting potent therapeutic efficacy | |
Xu, Jian; Du, Yue; Liu, Xiu-Jun; Zhu, Bing-Yan; Zhang, Sheng-Hua; Li, Liang; Li, Yi; Wang, Xiao-Fei; Shan, Chuan-Kun; Wang, Rui-Qi | |
2017 | |
卷号 | 126期号:,SI页码:66-76 |
关键词 | Fusion protein Delivery carrier EGFR/MMP-2 bi-targeted Enediyne Therapeutic efficacy |
ISSN号 | 1043-6618 |
DOI | 10.1016/j.phrs.2017.04.001 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6367830 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Xu, Jian,Du, Yue,Liu, Xiu-Jun,et al. Recombinant EGFR/MMP-2 bi-targeted fusion protein markedly binding to non-small-cell lung carcinoma and exerting potent therapeutic efficacy[J],2017,126(,SI):66-76. |
APA | Xu, Jian.,Du, Yue.,Liu, Xiu-Jun.,Zhu, Bing-Yan.,Zhang, Sheng-Hua.,...&Zhen, Yong-Su.(2017).Recombinant EGFR/MMP-2 bi-targeted fusion protein markedly binding to non-small-cell lung carcinoma and exerting potent therapeutic efficacy.,126(,SI),66-76. |
MLA | Xu, Jian,et al."Recombinant EGFR/MMP-2 bi-targeted fusion protein markedly binding to non-small-cell lung carcinoma and exerting potent therapeutic efficacy".126.,SI(2017):66-76. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论